A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.
Saved in:
| Title: | A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors. |
|---|---|
| Authors: | Karasic TB; University of Pennsylvania, Philadelphia, Pennsylvania, USA. thomas.karasic@pennmedicine.upenn.edu., Chiorean EG; University of Washington, Seattle, Washington, USA., Sebti SM; H. Lee Moffitt Cancer Care and Research Center, Tampa, FL, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania, USA. |
| Source: | Targeted oncology [Target Oncol] 2019 Oct; Vol. 14 (5), pp. 613-618. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31372813 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Karasic+TB%22">Karasic TB</searchLink>; University of Pennsylvania, Philadelphia, Pennsylvania, USA. thomas.karasic@pennmedicine.upenn.edu.<br /><searchLink fieldCode="AU" term="%22Chiorean+EG%22">Chiorean EG</searchLink>; University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Sebti+SM%22">Sebti SM</searchLink>; H. Lee Moffitt Cancer Care and Research Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22O'Dwyer+PJ%22">O'Dwyer PJ</searchLink>; University of Pennsylvania, Philadelphia, Pennsylvania, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2019 Oct; Vol. 14 (5), pp. 613-618. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31372813 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11523-019-00661-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 613 Titles: – TitleFull: A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Karasic TB – PersonEntity: Name: NameFull: Chiorean EG – PersonEntity: Name: NameFull: Sebti SM – PersonEntity: Name: NameFull: O'Dwyer PJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2019 Oct Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1776-260X Numbering: – Type: volume Value: 14 – Type: issue Value: 5 Titles: – TitleFull: Targeted oncology Type: main |
| ResultId | 1 |
